0000950170-24-062219.txt : 20240520 0000950170-24-062219.hdr.sgml : 20240520 20240520131030 ACCESSION NUMBER: 0000950170-24-062219 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240520 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Danimer Scientific, Inc. CENTRAL INDEX KEY: 0001779020 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 841924518 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39280 FILM NUMBER: 24963512 BUSINESS ADDRESS: STREET 1: 140 INDUSTRIAL BOULEVARD CITY: BAINBRIDGE STATE: GA ZIP: 39817 BUSINESS PHONE: 229-243-7075 MAIL ADDRESS: STREET 1: 140 INDUSTRIAL BOULEVARD CITY: BAINBRIDGE STATE: GA ZIP: 39817 FORMER COMPANY: FORMER CONFORMED NAME: Danimer Scientific, Inc DATE OF NAME CHANGE: 20201229 FORMER COMPANY: FORMER CONFORMED NAME: Live Oak Acquisition Corp DATE OF NAME CHANGE: 20200106 FORMER COMPANY: FORMER CONFORMED NAME: Foxhound Merger Partners, Inc. DATE OF NAME CHANGE: 20190605 8-K 1 dnmr-20240520.htm 8-K 8-K
false000177902000017790202024-05-202024-05-20

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 20, 2024

 

 

DANIMER SCIENTIFIC, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39280

84-1924518

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

140 Industrial Boulevard

 

Bainbridge, Georgia

 

39817

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 229 243-7075

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A Common stock, $0.0001 par value per share

 

DNMR

 

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On May 20, 2024, Stephen E. Croskrey informed Danimer Scientific, Inc. (the “Company”) of his intention to retire from employment with the Company on or before December 31, 2024. In connection therewith, the Company and Mr. Croskrey entered into a Transition and Retirement Agreement (the “Transition Agreement”), dated as of May 20, 2024 (the “Effective Date”).

The Transition Agreement provides that Mr. Croskrey is resigning from his position as Chairman of the Board of Directors of the Company (the “Board”) as of the Effective Date, and resigning from employment with the Company, effective as of a date on or before December 31, 2024 (the date of Mr. Croskrey’s separation from employment with the Company, the “Retirement Date”). Mr. Croskrey will remain a Director on the Board through the completion of the current term, which is scheduled to expire as of the Company’s annual meeting of stockholders to be held on or about July 9, 2024, and will be nominated as a Board member for the shareholder vote scheduled to take place at such meeting. The Board may request that Mr. Croskrey resign as a Director on the Board at any time after such meeting.

During the period between the Effective Date and the Retirement Date (the “Transition Period”), the Company may transfer Mr. Croskrey out of the Chief Executive Officer position and into the position of Special Advisor at any time; provided, that Mr. Croskrey’s compensation will remain unchanged during the Transition Period. Mr. Croskrey will not be eligible to receive any compensation in connection with his position as a Director on the Board during any portion of the Transition Period but will be eligible to receive the typical compensation paid by the Company to non-employee directors in connection with such position with respect to any portion of his Director term that continues following the end of the Transition Period, on a pro-rated basis. Mr. Croskrey will remain eligible to receive his 2024 annual incentive bonus, calculated based on the achievement of the applicable performance metrics as set forth in the Transition Agreement; in the event the minimum performance metric is not achieved, subject to Mr. Croskrey’s execution and non-revocation of a waiver and release of claims in favor of the Company and its affiliates (the “Release Condition”), Mr. Croskrey shall be eligible to receive the guaranteed 2024 annual incentive bonus set forth in the Transition Agreement. Mr. Croskrey will not receive any long-term incentive award as an employee for 2024 but may receive a new equity award in connection with his continued Board service following the Retirement Date, if applicable. Subject to the satisfaction of the Release Condition following the Retirement Date (and other terms as set forth in the Transition Agreement), (a) Mr. Croskrey’s outstanding long-term incentive awards will be amended to provide for continued vesting in accordance with the terms thereof as if Mr. Croskrey had continued service as a Director through the outside vesting date for such award and, in the case of stock option awards, an outside exercise date not later than the 10thanniversary of the original grant date; provided, that all performance stock awards will be forfeited as of the Retirement Date, and (b) subject to his timely election to continue coverage for himself and his dependent spouse under the Company’s group health plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), the Company will pay for monthly COBRA premiums following the Retirement Date and until the earlier of the date Mr. Croskrey becomes eligible to enroll in health insurance from an alternate employer or the end of the full COBRA period allowable under applicable law.

Except as otherwise provided in the Transition Agreement, the terms of Mr. Croskrey’s Amended and Restated Employment Agreement with the Company, dated July 23, 2021 (the “Employment Agreement”), will continue to govern the terms of Mr. Croskrey’s employment during the Transition Period. Mr. Croskrey will continue to be subject to the restrictive covenant obligations pursuant to the Employment Agreement.

Following Mr. Croskrey’s resignation from his role as Chairman of the Board, the Board appointed current Director, Richard Hendrix, as Chairman of the Board, inclusive of an Interim Executive Chairman role. The Board also formed an Executive Committee responsible for certain objectives, including the search for a successor Chief Executive Officer, which such committee is composed of Mr. Hendrix, David Moody (current Director), John Amboian (current Director), and Mr. Croskrey.

The foregoing description of the Transition Agreement does not purport to be complete and is subject to and qualified in its entirety by the terms and conditions of the Transition Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

d) Exhibits.

 

 

 

Exhibit No.

Description

10.1

Transition and Retirement Agreement, between Danimer Scientific, Inc. and Stephen E. Croskrey, dated as of May 20, 2024.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Danimer Scientific, Inc

 

 

 

 

Date:

May 20, 2024

By:

/s/ Stephen A. Martin

 

 

 

Stephen A. Martin
Chief Legal Officer and Corporate Secretary

 


EX-10.1 2 dnmr-ex10_1.htm EX-10.1 EX-10.1

 

Exhibit 10.1

TRANSITION AND RETIREMENT AGREEMENT

This Transition and Retirement Agreement (this “Agreement”), dated as of May 20, 2024 (the “Effective Date”), is entered into by and between Stephen E. Croskrey (“Executive”) and Danimer Scientific, Inc. (the “Company”). Executive and the Company are each referred to herein as a “Party” and together as the “Parties.” Capitalized terms used but undefined herein shall have the meanings attributed to them in that certain Amended and Restated Employment Agreement by and between Executive and the Company, dated July 23, 2021 (the “Employment Agreement”), a copy of which was filed as Exhibit 10.1 to the Company’s 8-K dated July 29, 2021.

WHEREAS, reference is made herein to (i) the Live Oak Acquisition Corp. 2020 Long-Term Incentive Plan (the “LTIP”; capitalized terms used but undefined in this paragraph shall have the meanings attributed to them in the LTIP or the applicable Award Agreement (as defined in the LTIP) thereunder (such Award Agreements collectively, the “Award Agreements”)) and (ii) the following equity awards made to Executive thereunder: (a) Restricted Stock Award dated March 10, 2021 granting in the aggregate 754,518 shares of restricted stock; (b) Non-Qualified Stock Option Award dated December 29, 2020 granting in the aggregate 2,571,737 Option Shares with an Exercise Price of $24.20; (c) Non-Qualified Stock Option Award dated July 23, 2021 granting in the aggregate 244,073 Option Shares with an Exercise Price of $18.24; (d) Non-Qualified Stock Option Award dated July 23, 2021 granting in the aggregate 1,154,616 Option Shares with an Exercise Price of $24.20; (e) Non-Qualified Stock Option Award dated March 15, 2022 granting in the aggregate 972,222 Option Shares with an Exercise Price of $3.99; (f) Non-Qualified Stock Option Award dated February 28, 2023 granting in the aggregate 300,000 Option Shares with an Exercise Price of $7.50; and (g) Non-Qualified Stock Option Award dated February 28, 2023 granting in the aggregate 750,000 Option Shares with an Exercise Price of $2.58;

WHEREAS, Executive intends to retire from employment with the Company on or before December 31, 2024. Executive’s actual date of separation from employment with the Company is referred to herein as the “Retirement Date”;

WHEREAS, Executive acknowledges that between the Effective Date and the Retirement Date (the “Transition Period”), the Company will be engaged in the process to identify and install a successor Chief Executive Officer (“CEO”) and the Company may require Executive’s assistance in transitioning the CEO role from Executive to such successor CEO; and,

WHEREAS, in connection with the Parties entry into this Agreement, the Parties wish to memorialize certain (i) rights and obligations of the Parties during the Transition Period, (i) terms of Executive’s employment, including compensation terms, that will be in effect during the Transition Period, and (ii) benefits for which Employee will be eligible following the Retirement Date, subject to Executive’s compliance with the terms of this Agreement.

NOW, THEREFORE, in consideration of the promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the Parties, the Parties agree as follows:

1


 

1.
Executive’s Notice of Resignation.
(a)
Executive hereby provides the Company with written notice of his resignation from the Company without Good Reason, pursuant to Section 3(l)(vi) of the Employment Agreement. Executive’s Retirement Date shall be a date on or before December 31, 2024.
(b)
Executive hereby resigns from his position as Chairman of the Board of Directors of the Company (the “Board”) as of the Effective Date. For the avoidance of doubt, Executive does not resign from his position as a Director of the Board as of the Effective Date.

The Parties hereby acknowledge and agree that this Agreement fully satisfies the termination notice obligations set forth in Section 3(q) of the Employment Agreement.

2.
Public Disclosures.
(a)
Executive and the Company agree to the statement attached hereto as Exhibit A as the initial public announcement of Executive’s planned retirement from the Company (the “Initial Disclosure”). The Executive and the Company agree that the Initial Disclosure shall be made on May 20, 2024, or such other date as mutually agreed by Executive and the Company.
(b)
Executive acknowledges that the Company shall make public disclosures regarding Executive’s notice of retirement and retirement as required by applicable law (a “Mandatory Disclosure”). The Company retains the authority to determine the content and timing of any Mandatory Disclosure, which shall be made in accordance with applicable law; to the extent consistent with the requirements of applicable law, the Mandatory Disclosure shall be consistent with the messaging in the Initial Disclosure.
(c)
The Company agrees that Executive is permitted to issue a public statement, consistent with the messaging in the Initial Disclosure, concerning Executive’s intention to retire from employment with the Company not later than December 31, 2024 (the “Executive Disclosure”). The Company and Executive shall cooperate to mutually agree upon timing and language of the Executive Disclosure, and Executive shall not unreasonably withhold consent to the Company’s proposals.
(d)
The Company shall have the right to make additional public disclosures, consistent with the messaging in the Initial Disclosure and this Agreement, regarding (i) Executive’s retirement, (ii) the Company’s search for a successor CEO, (iii) the Company’s plans for operation and governance during the Transition Period, and (iv) related matters. The Company shall seek input from Executive regarding such disclosures; however, the Company shall retain discretion regarding the ultimate nature and content of such disclosures.
3.
Board Actions.
(a)
Executive shall remain a Director on the Board through his current term, scheduled to expire as of the Company’s annual meeting of stockholders to be held on or about July 9, 2024 (the “2024 Annual Meeting”). Executive shall be included in the slate of nominated Board members for the 2024 shareholder vote scheduled to take place at the 2024 Annual Meeting. In the event the Board requests that Executive resign from his position as a Director on the Board

2


 

at any time after the 2024 Annual Meeting, Executive shall comply with such request and take all requisite action to promptly effectuate his resignation as a Director on the Board.
(b)
Executive acknowledges that, following his resignation from his role as Chairman of the Board as of the Effective Date, the Board shall elect a new Chairman of the Board. The Parties acknowledge that the Board intends to appoint current Director, Richard Hendrix (“Mr. Hendrix”) as Chairman of the Board, subject to Board approval. Executive acknowledges and agrees that, in the event the Board appoints Mr. Hendrix as Chairman of the Board, such position shall be inclusive of an Interim Executive Chairman role and Mr. Hendrix shall be delegated appropriate authorities with respect to rights to manage the Company and to direct Executive during the Transition Period.
(c)
The Parties acknowledge that (i) the Board intends to form an Executive Committee responsible for Company strategy, management transition, and the search for a successor CEO, and (ii) the Board intends for the following Directors to serve of such Executive Committee: Mr. Hendrix, David Moody, John Amboian (“Mr. Amboian”), and Executive, in each case, subject to Board approval. The Parties further acknowledge that the Board intends to appoint Mr. Amboian as Chair of the Compensation Committee of the Board, subject to Board approval.
4.
Retirement Date; Transition Period.
(a)
Unless earlier terminated by Executive or the Company in accordance with the terms of the Employment Agreement, Executive’s employment with the Company and any of its subsidiaries and affiliates, as applicable, shall end on December 31, 2024. As of the Retirement Date, Executive will have no further employment relationship with the Company or any of its subsidiaries and affiliates.
(b)
During the Transition Period:
(i)
Executive shall be subject to the direction of Mr. Hendrix in his role as Interim Executive Chairman, and Mr. Hendrix and the Company shall have the discretion to modify, alter, reduce, lessen or remove Executive’s authorities, duties, responsibilities or reporting structure in any manner;
(ii)
The Company shall have the right, in its sole discretion, to transfer Executive out of the CEO position and into the position of Special Advisor at any time prior to the Retirement Date (a “Transfer”). Following a Transfer, the Company may direct Executive to perform: (A) such duties as the Company reasonably determines necessary to assist in the transition of a successor CEO or (B) to perform no work. Regardless of any such Transfer, Executive’s compensation terms and conditions shall remain unchanged during the Transition Period;
(iii)
Executive shall not be eligible to receive any award, payment, compensation or other benefits as a result of or in connection with Executive’s status as a Director of the Board during any portion of the Transition Period; provided, in the event that Executive holds a position as Director of the Board during any term that includes a portion of the Transition Period and continues after the end of the Transition Period, Executive shall be eligible to receive any applicable award, payment, compensation or other benefit arising as a result of or in connection with such position, multiplied by a

3


 

fraction, the denominator of which is the total number of days in the term of Executive’s positions as a Director of the Board and the numerator of which is the number of days during such term following the end of the Transition Period, subject to the applicable terms and conditions of such award, payment, compensation or other benefit; and
(iv)
except as otherwise provided in this Agreement, the terms of the Employment Agreement shall continue to govern the terms of Executive’s employment with the Company.
(c)
By executing this Agreement, Executive has provided the Company and the Board (and any member or committee thereof) with Executive’s written consent for the Company and the Board (and any member or committee thereof) to execute this Agreement, and to take any action (or omission to act) reasonably contemplated by this Agreement, including the changes to Executive’s employment positions, authority, duties, responsibilities, or reporting structure. Notwithstanding anything in this Agreement, the Employment Agreement or any other agreement between Executive and the Company to the contrary, Executive agrees and acknowledges that in no event shall any action (or omission to act) by the Company or the Board (or any member or committee thereof), in each case taken pursuant to and consistent with the terms of this Agreement, including for the avoidance of doubt the execution of this Agreement, actions (or omissions to act) by any Person in connection herewith, including the implementation of a Transfer or otherwise operating under the transition structure and scheme resulting from Executive’s notice of retirement and this Agreement, and any event or condition resulting therefrom, constitute a breach of any provision of the Employment Agreement (material or otherwise), a termination of Executive’s employment without Cause (including as a matter of constructive discharge), or Good Reason for Executive to terminate Executive’s employment with the Company. Executive expressly waives any right Executive may have to claim or assert that the Company has terminated Executive’s employment with the Company without Cause, or that Executive has Good Reason to terminate Executive’s employment with the Company, in each case as a result of or in connection with any of the actions (or omissions to act) the Company or the Board is permitted to take under this Agreement.
5.
2024 Incentive Awards.
(a)
With respect to Executive’s Annual Incentive Award for 2024, as provided for in the Employment Agreement, the minimum bonus target shall be the $49,872,243 target (the “Minimum Target”) set forth in the 2024 PHA Sales Bonus Grid previously established by the Company (the “Bonus Grid”) and the maximum bonus target shall be the $74,808,365 target (the “Maximum Target”) set forth in the Bonus Grid, with each of the interim target thresholds between the Minimum Target and the Maximum Target remaining as reflected in the Bonus Grid (each, an “Interim Target”). Provided that Executive is in compliance with this Agreement and his obligations to the Company with respect to the Transition Period, the 2024 Annual Incentive Award shall be as follows: (i) if the Minimum Target is achieved, 1.25 times Executive’s Annual Base Salary, (ii) if an Interim Target is achieved, between 1.25 times and 2.5 times his Annual Base Salary scaled ratably depending on the level of Interim Target achieved, or (iii) if the Maximum Target is achieved, 2.5 times his Annual Base Salary. In the event the Company does not achieve at least the Minimum Target, provided that Executive is in compliance with this Agreement and his obligations to the Company with respect to the Transition Period, and subject to Executive’s timely execution and non-revocation of a waiver and release of claims in favor of

4


 

the Company and its affiliates in a form substantially similar to the form attached hereto as Exhibit B (the “Release”), Executive shall be eligible to receive .625 times his Annual Base Salary. Such Release shall not require Executive to Release the Company from satisfaction of any vested benefit obligations owed by the Company, but not yet provided to Executive pursuant to this Agreement. For the avoidance of doubt, in the event of achievement in excess of the Maximum Target, the actual amount of the 2024 Annual Incentive Award will be capped at 2.5 times Executive’s Annual Base Salary. Whether the Company has identified a successor CEO shall have no impact on Executive’s eligibility for the Annual Incentive Award for 2024. The Annual Incentive Award for 2024 will be paid no later than March 15, 2025.
(b)
Executive shall not receive any Long Term Incentive Award as an employee for 2024. Executive shall not receive any new equity grants other than in connection with his continued service, if any, on the Board following the Retirement Date.
6.
Obligations Upon Termination. Provided that (a) Executive’s employment with the Company is not terminated by the Company for Cause prior to or as of the Retirement Date; (b) Executive timely executes (and does not revoke) and delivers to the Company a Release on or following the Retirement Date; and (c) Executive complies with each of Executive’s obligations set forth herein, and all other ongoing obligations to the Company, including those obligations set forth in Sections 4(r) and 5 of the Employment Agreement, then:
(i)
reasonably promptly after the date that the Release becomes effective, with respect to Executive’s outstanding LTIP awards issued prior to the Effective Date pursuant to the LTIP and the Award Agreements, the Board shall take such action as is necessary to cause the Committee (as defined in the LTIP) to amend the Award Agreements, as applicable, to provide for continued vesting in accordance with the terms thereof as if Executive remained a Director on the Board through the outside vesting date for such award and, in the case of stock option awards, an outside exercise date not later than the 10th anniversary of the original grant date. For the avoidance of doubt all performance stock awards shall be forfeited as of the Retirement Date; and,
(ii)
reasonably promptly after the date that the Release becomes effective, the Company shall transfer title or ownership, as applicable, to Executive of: (A) the Company-owned vehicle provided to Executive for use during Executive’s employment with the Company (2018 Ford 150), and (B) any Company-owned laptops and/or cell phones provided to Executive for use during Executive’s employment with the Company (collectively, the “Devices”); provided, however, before such transfer with respect to the Devices occurs, the Company shall be afforded reasonable opportunity and access to the Devices to review the contents of the Devices and remove or delete therefrom of any information belonging to the Company or its affiliates, including for the avoidance of doubt any Proprietary Information; and
(iii)
subject to Executive’s timely election to continue coverage for Executive and Executive’s dependent spouse, under the Company’s group health plans pursuant to Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), the Company shall remit direct payment on Executive’s behalf on a monthly basis for an amount not to exceed the full amount of the monthly health insurance premium payment for active Company employees (the “Monthly COBRA Amount”) for the period

5


 

beginning on the Retirement Date and ending on the earlier of (1) the date Executive becomes eligible to enroll in health insurance from an alternate employer (and, in such case, Executive shall notify the Company of such eligibility within five days following becoming eligible) or (2) the end of the full COBRA period allowable under applicable law. Notwithstanding the foregoing, if the provision of the benefits described in this paragraph cannot be provided in the manner described above without penalty, tax or other adverse impact on the Company or its affiliates, then the Company and Executive shall negotiate in good faith to determine an alternative manner in which the Company may provide substantially equivalent benefits to Executive without such adverse impact on the Company or its affiliates.
7.
Attorney’s Fees. Provided that Executive provides the Company with documentation reasonably substantiating the attorney’s fees actually incurred by Executive arising from or in connection with the negotiation and execution of this Agreement within fifteen (15) days of the Effective Date, the Company shall reimburse Executive for such fees in an amount not to exceed fifteen-thousand ($15,000) dollars.
8.
Severability. Any term or provision of this Agreement (or part thereof) that renders such term or provision (or part thereof) or any other term or provision hereof (or part thereof) invalid or unenforceable in any respect shall be severable and shall be modified or severed to the extent necessary to avoid rendering such term or provision (or part thereof) invalid or unenforceable, and such modification or severance shall be accomplished in the manner that most nearly preserves the benefit of the bargain set forth in this Agreement.
9.
Reaffirmation of Covenants.
(a)
Executive acknowledges and agrees that Executive has continuing obligations to the Company pursuant to Section 5 of the Employment Agreement (such obligations, the “Restrictive Covenants”). In entering into this Agreement, Executive acknowledges the continued effectiveness and enforceability of the Restrictive Covenants and expressly reaffirms Executive’s commitment to abide by (and agrees that Executive will abide by) the terms of the Restrictive Covenants during and after the Transition Period.
(b)
The Company acknowledges and agrees that it has continuing obligations to Executive pursuant to Section 2(n) of the Employment Agreement (such obligations, the “Indemnification Obligation”). In entering into this Agreement, the Company acknowledges the continued effectiveness and enforceability of the Indemnification Obligation and expressly reaffirms the Company’s commitment to abide by (and agrees that the Company will abide by) the terms of the Indemnification Obligation during and after the Transition Period.
10.
Lease Agreement. The Company and Executive are parties to that certain Lease Agreement dated on or about April 15, 2016, as amended by the letter agreement dated September 24, 2020, with respect to the house located at 240 Back of the Moon Road, Brinson, Georgia 39825 (the “Lease Agreement”). The Company and Executive agree that (i) the Lease Agreement shall remain in effect through the Retirement Date, on which such date it shall terminate, and (ii) the Purchase Option as defined in the Lease Agreement shall remain exercisable by Executive through the Retirement Date, on which such date the Purchase Option shall expire. The Company and Executive agree that, in the event the termination or expiration terms set forth in the Lease

6


 

Agreement conflict with the terms set forth in (i) and (ii) in the preceding sentence, the Lease Agreement is hereby amended to reflect the termination and expiration terms set forth in (i) and (ii) in the preceding sentence.
11.
Amendments; Waivers. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized representative of Company. By an instrument in writing similarly executed, Executive or a duly authorized representative of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.
12.
Entire Agreement. This Agreement (and, as referenced herein, the Employment Agreement and the Award Agreements, each as modified by this Agreement) constitutes the entire agreement of the parties hereto with regard to the subject matters hereof and supersede all prior and contemporaneous agreements and understandings, oral or written, between Executive and the Company with regard to the subject matter hereof; provided, however, this Agreement complements and is in addition to (and does not replace or supersede) any obligations of Executive with respect to confidentiality, non-disclosure, non-solicitation, protection of trade secrets, non-disparagement, or return of property (regardless of whether such obligations arise from contract, common law, statute, or otherwise).
13.
Construction. This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (i) the plural includes the singular and the singular includes the plural; (ii) “and” and “or” are each used both conjunctively and disjunctively; (iii) “any,” “all,” “each,” or “every” means “any and all,” and “each and every”; (iv) “includes” and “including” are each “without limitation”; (v) “herein,” “hereof,” “hereunder” and other similar compounds of the word “here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (vi) all pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.
14.
Withholding and Taxes. The Company may withhold from all payments made pursuant to this Agreement all federal, state, local, and other taxes and withholdings as may be required pursuant to any law or governmental regulation or ruling. Executive shall be responsible for all applicable taxes associated with his receipt of all benefits provided for under this Agreement.
15.
Counterparts. This Agreement may be executed in one or more counterparts (including portable document format (.pdf) and facsimile counterparts), each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.

7


 

 

16.
Applicable Law and Venue. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the State of Delaware without reference to the principles of conflicts of law of the State of Delaware or any other jurisdiction that would result in application of the laws of a jurisdiction other than the State of Delaware, and where applicable, the laws of the United States. Any action or proceeding arising out of or relating to this Agreement shall be brought exclusively in the Delaware Chancery Court, or, if the Delaware Chancery Court does not have subject matter jurisdiction, in the federal courts located in the State of Delaware, and the parties hereby expressly represent and agree that they are subject to the personal jurisdiction of said courts, and the parties hereby irrevocably consent to the jurisdiction of such courts in any legal or equitable proceedings related to such disputes and waive, to the fullest extent permitted by law, any objection which either of them may now or hereafter have that the laying of the venue of any legal proceedings related to such dispute which is brought in any such courts is improper or that such proceedings have been brought in an inconvenient forum. The Parties hereto agree to service of process by certified or registered United States mail, postage prepaid, addressed to the Party in question. The Parties hereto irrevocably waive the right to a jury trial in connection with any action arising under this Agreement or the employment of Executive.

 

17.
Section 409A. This Agreement and the payments provided hereunder are intended to comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue Code of 1986 and the Treasury regulations and interpretive guidance issued thereunder (collectively, “Section 409A”) and shall be construed and administered in accordance with such intent. For purposes of Section 409A, any installment payments shall each be treated as separate payments. Notwithstanding the foregoing, the Company makes no representations that the benefits provided under this Agreement are exempt from or comply with the requirements of Section 409A and in no event shall the Company or any other Company Party be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by Executive on account of non-compliance with Section 409A. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the Company at the time of Executive’s “separation from service” from the Company within the meaning of Section 409A to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (a) the expiration of the six-month period measured from the date of Executive’s separation from service with the Company or (b) the date of Executive’s death. Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein. To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31st of the year following the year in which the expense is incurred; provided, that Executive submits Executive’s reimbursement request promptly following the date the expense is incurred (or as otherwise required pursuant to this Agreement), the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses referred to in Section 105(b) of the Code, and

8


 

Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.

 

[Remainder of Page Intentionally Blank;
Signature Page Follows
]

 

9


 

IN WITNESS WHEREOF, the Parties hereto have knowingly and voluntarily executed this Agreement as of the date set forth below, effective for all purposes as provided above.

 

 

Stephen E. Croskrey

 

 

/s/ Stephen E. Croskrey

Stephen E. Croskrey

 

Date: May 20, 2024

 

 

 

Danimer Scientific, Inc.

 

 

/s/ Richard J. Hendrix

By: Richard J. Hendrix

Title: Interim Executive Chairman

 

Date: May 20, 2024

 


EX-101.SCH 3 dnmr-20240520.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
May 20, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 20, 2024
Entity Registrant Name DANIMER SCIENTIFIC, INC.
Entity Central Index Key 0001779020
Entity Emerging Growth Company false
Entity File Number 001-39280
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 84-1924518
Entity Address, Address Line One 140 Industrial Boulevard
Entity Address, City or Town Bainbridge
Entity Address, State or Province GA
Entity Address, Postal Zip Code 39817
City Area Code 229
Local Phone Number 243-7075
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common stock, $0.0001 par value per share
Trading Symbol DNMR
Security Exchange Name NYSE
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports dnmr-20240520.htm dnmr-20240520.xsd http://xbrl.sec.gov/dei/2024 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "dnmr-20240520.htm": { "nsprefix": "dnmr", "nsuri": "http://danimerscientific.com/20240520", "dts": { "inline": { "local": [ "dnmr-20240520.htm" ] }, "schema": { "local": [ "dnmr-20240520.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_cbd8629e-dab7-4156-ae35-8a2f6d1e9bf8", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "dnmr-20240520.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_cbd8629e-dab7-4156-ae35-8a2f6d1e9bf8", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "dnmr-20240520.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://danimerscientific.com/20240520/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000950170-24-062219-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-062219-xbrl.zip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end XML 15 dnmr-20240520_htm.xml IDEA: XBRL DOCUMENT 0001779020 2024-05-20 2024-05-20 false 0001779020 8-K 2024-05-20 DANIMER SCIENTIFIC, INC. DE 001-39280 84-1924518 140 Industrial Boulevard Bainbridge GA 39817 229 243-7075 false false false false Class A Common stock, $0.0001 par value per share DNMR NYSE false